Oncolytics Biotech Inc. (ONCY)

Oncolytics Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	103	94	70	100	96	76
Market Cap Growth	121.29%	33.53%	-29.42%	3.71%	25.79%	-25.81%
Enterprise Value	99	86	57	71	73	39
Last Close Price	0.89	0.87	0.91	1.35	1.63	1.39
PB Ratio	-	-24.76	21.36	4.78	4.91	2.68
P/TBV Ratio	-	-	21.36	4.78	4.91	2.68
Debt / Equity Ratio	-0.15	-0.15	0.23	0.02	0.01	0.02
Net Debt / Equity Ratio	1.22	1.22	-3.13	-1.25	-1.20	-1.12
Net Debt / EBITDA Ratio	0.16	0.16	0.41	1.02	1.18	1.56
Net Debt / FCF Ratio	0.23	0.23	0.51	1.21	1.36	1.79
Quick Ratio	0.95	0.95	2.28	8.24	8.15	15.37
Current Ratio	1.12	1.12	2.55	9.01	9.05	16.69
Return on Equity (ROE)	-	-	-203.03%	-102.66%	-79.34%	-86.45%
Return on Assets (ROA)	-170.96%	-170.96%	-79.03%	-55.46%	-40.44%	-40.88%
Return on Capital Employed (ROCE)	-1939.60%	-1939.60%	-299.20%	-97.70%	-80.60%	-60.70%
Earnings Yield	-27.83%	-30.58%	-32.36%	-21.06%	-19.07%	-27.18%
FCF Yield	-19.47%	-21.39%	-28.48%	-21.59%	-17.98%	-23.47%
Buyback Yield / Dilution	-25.33%	-25.33%	-13.10%	-16.53%	-8.44%	-32.66%

Updated Mar 30, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q